A majority of the panel members — 20 in all — voted to tell the Food and Drug Administration to keep the drug on the market with various new restrictions and warnings. Those votes were split among three choices, but taken together they supported continued availability of Avandia.
The single biggest vote-getter, though, was the choice to withdraw Avandia from the market. Twelve panel members essentially said the risks of heart trouble from the drug aren't worth it. As Wake Forest's Dr. Curt Furberg, a nay, put it: Avandia "has serious adverse effects that overwhelm any benefits." What's more, he said, safer alternatives are available.
via npr.org
1 comment:
Exactly, there are many safer alternatives available to control diabetes. I think we need to wait for some time to understand the effects of Avandia properly.
Post a Comment